Financiële Persberichten

05-09-2017 VIVAT Interim Results 2017 Update
05-09-2017 VIVAT Interim Results 2017 Update Presentation
19-06-2017 Solvency Financial Condition Report 2016
15-06-2017 Reaction on various international media reports about Anbang
10-05-2017 VIVAT has priced eur 650 million of senior notes
26-04-2017 Jaarverslag SRLEV N.V. 2016
06-04-2017 Jaarverslag VIVAT N.V. 2016
09-03-2017 VIVAT Jaarcijfers 2016
18-11-2016 SRLEV NV decides not to exercise its option in December 2016 to redeem its CHF 105 mln undated subordinated bonds issued in 2011
31-08-2016 VIVAT Trading Update: Goede voortgang van nieuwe strategie
25-05-2016 VIVAT bevestigt benoeming nieuwe bestuursleden
11-04-2016 Wijzigingen in de Raad van Bestuur
15-03-2016 Nieuwe bestuursvoorzitter VIVAT
11-03-2016 VIVAT Jaarcijfers 2015
26-10-2015 Management changes to VIVAT NV and subsidiaries
23-10-2015 VIVAT NV receives EUR 1.35 billion capital injection from Anbang Insurance Group
23-10-2015 SRLEV NV will pay deferred interest and resume coupon payments on its subordinated bonds
14-09-2015 Press release Gerard van Olphen steps down as Chairman of the Executive Board of VIVAT NV
26-07-2015 Anbang Insurance Group completes the acquisition of SNS REAAL NV’s subsidiary VIVAT
26-07-2015 Management changes to VIVAT NV
02-04-2015 Final split up of SNS REAAL in the course of 2015
09-03-2015 SRLEV postpones coupon payment on EUR 400 million subordinated bonds due 2041 (ISIN CODE XS0616936372)
16-02-2015 SNS REAAL announces sale VIVAT Verzekeringen to Anbang
05-12-2014 SRLEV postpones coupon payment on CHF105,000,000 undated callable subordinated bonds

Archief financiële persberichten SNS REAAL

Contactinformatie

Victor Zijlema
T: +31 (0)20 - 543 60 53
M: +31 (0)6 - 239 177 18
E: Victor.Zijlema@vivat.nl

Michiel Kok
T: +31 (0)20 - 543 60 39
M: +31 (0)6 - 539 26 777
E: Michiel.Kok@vivat.nl